Dividend Announcement for Glaxosmithkline Pharmaceuticals Ltd - May 13, 2026

On May 13, 2026, shareholders are set to receive a dividend payout, with each share entitling its holder to a dividend of 570.0%. This dividend percentage reflects a significant return on investment, indicating a strong financial performance by the company. The dividend amount, at ₹57 per share, underscores the commitment of the company to distribute profits among its shareholders. This dividend is classified as Final. Shareholders who hold shares up to the ex-dividend date May 29, 2026 will qualify for this dividend payment, serving as a reward for their investment in the company's growth and success.